View of To what extent can dual inhibition of TRPV1 (Transient Receptor Potential Vanilloid-1) and PTGS2 (Prostaglandin- Endoperoxide Synthase 2) be achieved to alleviate pain in patients with refractory primary dysmenorrhea?

Return to Issue Details To what extent can dual inhibition of TRPV1 (Transient Receptor Potential Vanilloid-1) and PTGS2 (Prostaglandin- Endoperoxide Synthase 2) be achieved to alleviate pain in patients with refractory primary dysmenorrhea? Download Download PDF